文献速递腹部CT

基于CT的肝表面结节度检测临床显著门静脉高压:定义测量质量标准

CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

本研究在74例肝硬化患者(其中30例有临床显著门静脉高压)中,评估基于CT的肝表面结节度(LSN)测量诊断临床显著门静脉高压的准确性与可重复性,并由三名独立阅片者每人进行15次LSN测量。结果显示诊断准确率随测量次数增加而提高,在8次测量后趋于稳定,且8次测量时观察者内和观察者间一致性均极好。作者建议至少使用8次有效测量来确定平均LSN值以检测临床显著门静脉高压。

要点

  • LSN诊断CSPH的AUROC在8次测量后趋于稳定,8至15次测量间无显著差异。
  • 8次测量时观察者内ICC=0.90(95%CI 0.84-0.94),观察者间ICC=0.93(95%CI 0.89-0.95)。
  • 作者建议至少使用8次有效测量来确定平均LSN值以检测CSPH。

核心结论

  • 基于CT的LSN测量具有高度可重复性和准确性,作者建议至少使用8次有效测量来确定平均LSN值以检测CSPH。

研究设计与样本

  • 单中心连续纳入74例肝硬化患者(平均年龄62±13岁),其中30例(41%)有CSPH,均接受CT和肝静脉压力梯度测量。
  • 三名独立阅片者使用专用软件每人进行15次LSN测量,基于1至15次测量的中位数和均值计算LSN。
  • 以肝静脉压力梯度测量为参考标准,采用ROC曲线分析诊断CSPH的准确性,采用ICC和Bland-Altman图评估变异性。

诊断标准与关键数值

  • 基于1至15次测量的平均LSN的AUROC范围为0.79±0.05至0.91±0.04,中位数LSN的AUROC范围为0.86±0.04至0.91±0.03,两两比较均无显著差异(所有p>0.05)。
  • LSN的AUROC从1次测量到8次测量逐渐增加,在8至15次测量之间趋于平稳。
  • 8次测量时观察者内ICC=0.90(95%CI 0.84-0.94),观察者间ICC=0.93(95%CI 0.89-0.95)。
  • 8次测量时观察者内Bland-Altman偏倚为4.2%(95%一致性界限[-15.3; +23.7%]),观察者间偏倚为4.8%(95%一致性界限[-17.5; +27.1%])。
  • 观察者内和观察者间变异性从1次到15次测量逐渐降低,超过8次测量后仅有轻微改善。

临床应用与阅片要点

  • 作者建议使用至少8次有效测量来确定平均LSN值,以检测CSPH。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To establish measurement quality criteria for the noninvasive assessment of clinically significant portal hypertension (CSPH) in patients with cirrhosis using CT-based liver surface nodularity (LSN) measurements.

METHODS: Seventy-four consecutive patients with cirrhosis (mean 62 ± 13 years), including 30 with CSPH (41%), underwent CT and hepatic venous pressure gradient measurements. Three independent readers performed 15 LSN measurements/patient using dedicated software. LSN was computed based on the median and means of one to 15 measurements. Accuracy for diagnosing CSPH was assessed using receiver operating characteristic (ROC) curve analysis. Variability was assessed by the intra-class correlation coefficient (ICC) and the Bland-Altman plot (BA). Quality criteria were identified to maximize the accuracy of LSN and minimize variability.

RESULTS: The area under the (AU) ROCs of mean and median LSN measurements based on one to 15 measurements ranged from 0.79 ± 0.05 to 0.91 ± 0.04 and 0.86 ± 0.04 to 0.91 ± 0.03, respectively, with no difference on pair-wise comparisons (all p > 0.05). AUROCs of LSN increased from one to eight and leveled off between eight and 15 measurements. Inter- and intra-reader variability decreased from one to 15 measurements, with only slight improvement after more than eight measurements. Intra- and inter-observer agreements were excellent with eight measurements (ICC = 0.90 [95%CI 0.84-0.94], and ICC = 0.93 [95%CI 0.89-0.95], respectively), and variability for intra-observer and inter-observer agreement was low (BA bias 4.2% (95% limits of agreement [LoA] [- 15.3; + 23.7%]) and 4.8% LoA [ - 17.5; + 27.1%], respectively).

CONCLUSIONS: CT-based LSN measurement is highly reproducible and accurate. We suggest using at least 8 valid measurements to determine the mean LSN value for the detection of CSPH.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Sartoris R, Lazareth M, Nivolli A, et al. CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria. Abdom Radiol (NY). 2020. PMID: 32270261. doi:10.1007/s00261-020-02519-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。